ASB Tri-Axis Dominant-Primary Series I-NP

Vitis vinifera

Grape

Tier IASB Tri-Axis Dominant-Primary Series

Target Trait

1.1×

fold-change

Astringency-dominant tri-axis S+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-02630

Genomic Edits

GC Content

44.8%

Construct Length

4,287 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

Polyphenol-astringency axis + TAS1R2/TAS1R3 + TAS2R38 (suppression)

IFI Score

110

Pathway Edits

Polyphenol-astringency axis pathway primary gene cluster for astringency (IFI-A) tri-axis component
TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent ASB pathway operation
Cross-pathway regulatory circuit for astringency-dominant ASB triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: Polyphenol-astringency axis, TAS1R2/TAS1R3, and TAS2R38 (suppression) pathways simultaneously engineeredAstringency-dominant tri-axis expression strategy (ASB) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier I ASB triple-axis construct for advanced multi-modal sensory architecture combining astringency, sweet, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$549 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities